Biohaven Announces Exclusive License With Catalent For Zydis® Orally Dissolving Tablet With Small Molecule CGRP Receptor Antagonists
TFF Pharmaceuticals and Catalent Announce New Inhalation Dry Powder Development and Manufacturing Agreement
Bloomington's Catalent to hire 1,000 new employees paying on average $32 per hour, and invest at least $350 million | WBIW
Catalent Pharma on Twitter: "Catalent Development San Diego wins 4 awards in the 'Small Pharma' categories of the 2018 CMO Leadership Awards. View the full press release here: https://t.co/TNzKZWiiic #CMOLeadershipAwards # Catalent #pharmasolutions
Catalent pulls off $1.2B deal for gene therapy CDMO Paragon Bioservices | Fierce Pharma
Labconco Equipment Used to Speed Up Drug Discovery - Labconco
News and Events - Catalent
Technology, not capacity, driving Catalent's biologics strategy
Catalent Invests Additional $230 Million to Expand its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland · BioBuzz
Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA | corporate
Definitive Proxy Statement
Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader | Business Wire
Catalent increases spray drying capacity at Pharmatek
Saint-Gobain launches glass circular economy program at 2 facilities in California - Recycling Today
Perrigo and Catalent Announce FDA Approval of Generic ProAir® HFA
Exelixis and Catalent Enter into Collaboration, License, and Exclusive Option Agreement to Develop Antibody-Drug Conjugates Leve
Catalent To Open New Clinical Supply Facility In San Diego | World Pharma Today
Catalent Biologics - BIO International Convention | BIO
Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash
Bloomington's Catalent to Hire 1,000 New Employees at Average Wages of $32 an Hour or More, and Invest at Least $350 Million | City of Bloomington, Indiana
ERYTECH Provides Business and Financial Update for the First Half of 2022
Catalent to manufacture Moderna's personalized cancer vaccine